11
Aug
2017

Grail Plucks Low-Hanging Fruit, eGenesis Creates PERV-Free Pigs, & Roivant Raises $1B

Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more.

 
 

You may also like

Biotech Legend Retires, Jazz Buys Glioma Drug, & FDA Shakeup
Bluebird Fire Sale, Regeneron’s Gene Therapy for Deafness, & Eikon Raises a Bundle
Defend Young Scientists
Defend the FDA